Feline Atopic Dermatitis Drug Market 2027 By Drug Class, Route Of Administration, Distribution Channel and Geography | The Insight Partners

Feline Atopic Dermatitis Drug Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Drug Class (Corticosteroids, Antihistamines, Antibiotics) ; Route Of Administration (Oral, Topical, Injectable) ; Distribution Channel (Veterinary Pharmacies, Hospital Pharmacies, Retail Pharmacies) and Geography

Report Code: TIPRE00008619 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Feline Atopic Dermitis, also known as "Atopy" is an environmental allergy of the skin. It is a pruritic disease in which affected cats have a hypersensitivity reaction to inhaled or contacted environmental allergens. The age of onset is variable but generally is <5 yr.

MARKET DYNAMICS

Rising prevalence of feline atopic dermatitis is the major factor driving the market. For instance, as per Canadian Veterinary Journal it was reported that prevalence of feline atopy was reported to be 12.5%. Moreover, increasing trend of companion animal in the developing economies is further going to spur the market growth.

MARKET SCOPE

The "Global Feline Atopic Dermatitis Drug Market analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Feline Atopic Dermatitis Drug Market with detailed market segmentation by drug class, route of administration, distribution channel and geography. The Global Feline Atopic Dermatitis Drug Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Feline Atopic Dermatitis Drug Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Feline Atopic Dermatitis Drug Market is segmented on the basis of drug class, route of administration and distribution channel. On the basis of drug class, market can be classified as corticosteroids, antihistamines and antibiotics. Based on route of administration the market is segmented into oral, topical and injectable. Based on distribution channel the market is segmented into veterinary pharmacies, hospital pharmacies and retail pharmacies.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Feline Atopic Dermatitis Drug Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Feline Atopic Dermatitis Drug Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Feline Atopic Dermatitis Drug Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Feline Atopic Dermatitis Drug Market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Feline Atopic Dermatitis Drug Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Feline Atopic Dermatitis Drug Market are anticipated to lucrative growth opportunities in the future with the rising demand for Feline Atopic Dermatitis Drug Market in the global market. Below mentioned is the list of few companies engaged in the Feline Atopic Dermatitis Drug Market.

The report also includes the profiles of key Feline Atopic Dermatitis Drug Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Bausch Health Companies
- Bayer
- Pfizer
- Novartis
- Sanofi
- Eli Lily
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Elanco

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Feline Atopic Dermatitis Drug Market - By Drug Class
1.3.2 Feline Atopic Dermatitis Drug Market - By Route Of Administration
1.3.3 Feline Atopic Dermatitis Drug Market - By Distribution Channel
1.3.4 Feline Atopic Dermatitis Drug Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. FELINE ATOPIC DERMATITIS DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. FELINE ATOPIC DERMATITIS DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. FELINE ATOPIC DERMATITIS DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. FELINE ATOPIC DERMATITIS DRUG - GLOBAL MARKET OVERVIEW
6.2. FELINE ATOPIC DERMATITIS DRUG - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. FELINE ATOPIC DERMATITIS DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. CORTICOSTEROIDS
7.3.1. Overview
7.3.2. Corticosteroids Market Forecast and Analysis
7.4. ANTIHISTAMINES
7.4.1. Overview
7.4.2. Antihistamines Market Forecast and Analysis
7.5. ANTIBIOTICS
7.5.1. Overview
7.5.2. Antibiotics Market Forecast and Analysis
8. FELINE ATOPIC DERMATITIS DRUG MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. TOPICAL
8.4.1. Overview
8.4.2. Topical Market Forecast and Analysis
8.5. INJECTABLE
8.5.1. Overview
8.5.2. Injectable Market Forecast and Analysis
9. FELINE ATOPIC DERMATITIS DRUG MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. VETERINARY PHARMACIES
9.3.1. Overview
9.3.2. Veterinary Pharmacies Market Forecast and Analysis
9.4. HOSPITAL PHARMACIES
9.4.1. Overview
9.4.2. Hospital Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. FELINE ATOPIC DERMATITIS DRUG MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Feline Atopic Dermatitis Drug Market Overview
10.1.2 North America Feline Atopic Dermatitis Drug Market Forecasts and Analysis
10.1.3 North America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Drug Class
10.1.4 North America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Route Of Administration
10.1.5 North America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Countries
10.1.6.1 United States Feline Atopic Dermatitis Drug Market
10.1.6.1.1 United States Feline Atopic Dermatitis Drug Market by Drug Class
10.1.6.1.2 United States Feline Atopic Dermatitis Drug Market by Route Of Administration
10.1.6.1.3 United States Feline Atopic Dermatitis Drug Market by Distribution Channel
10.1.6.2 Canada Feline Atopic Dermatitis Drug Market
10.1.6.2.1 Canada Feline Atopic Dermatitis Drug Market by Drug Class
10.1.6.2.2 Canada Feline Atopic Dermatitis Drug Market by Route Of Administration
10.1.6.2.3 Canada Feline Atopic Dermatitis Drug Market by Distribution Channel
10.1.6.3 Mexico Feline Atopic Dermatitis Drug Market
10.1.6.3.1 Mexico Feline Atopic Dermatitis Drug Market by Drug Class
10.1.6.3.2 Mexico Feline Atopic Dermatitis Drug Market by Route Of Administration
10.1.6.3.3 Mexico Feline Atopic Dermatitis Drug Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Feline Atopic Dermatitis Drug Market Overview
10.2.2 Europe Feline Atopic Dermatitis Drug Market Forecasts and Analysis
10.2.3 Europe Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Route Of Administration
10.2.5 Europe Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Feline Atopic Dermatitis Drug Market
10.2.6.1.1 Germany Feline Atopic Dermatitis Drug Market by Drug Class
10.2.6.1.2 Germany Feline Atopic Dermatitis Drug Market by Route Of Administration
10.2.6.1.3 Germany Feline Atopic Dermatitis Drug Market by Distribution Channel
10.2.6.2 France Feline Atopic Dermatitis Drug Market
10.2.6.2.1 France Feline Atopic Dermatitis Drug Market by Drug Class
10.2.6.2.2 France Feline Atopic Dermatitis Drug Market by Route Of Administration
10.2.6.2.3 France Feline Atopic Dermatitis Drug Market by Distribution Channel
10.2.6.3 Italy Feline Atopic Dermatitis Drug Market
10.2.6.3.1 Italy Feline Atopic Dermatitis Drug Market by Drug Class
10.2.6.3.2 Italy Feline Atopic Dermatitis Drug Market by Route Of Administration
10.2.6.3.3 Italy Feline Atopic Dermatitis Drug Market by Distribution Channel
10.2.6.4 Spain Feline Atopic Dermatitis Drug Market
10.2.6.4.1 Spain Feline Atopic Dermatitis Drug Market by Drug Class
10.2.6.4.2 Spain Feline Atopic Dermatitis Drug Market by Route Of Administration
10.2.6.4.3 Spain Feline Atopic Dermatitis Drug Market by Distribution Channel
10.2.6.5 United Kingdom Feline Atopic Dermatitis Drug Market
10.2.6.5.1 United Kingdom Feline Atopic Dermatitis Drug Market by Drug Class
10.2.6.5.2 United Kingdom Feline Atopic Dermatitis Drug Market by Route Of Administration
10.2.6.5.3 United Kingdom Feline Atopic Dermatitis Drug Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Feline Atopic Dermatitis Drug Market Overview
10.3.2 Asia-Pacific Feline Atopic Dermatitis Drug Market Forecasts and Analysis
10.3.3 Asia-Pacific Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Route Of Administration
10.3.5 Asia-Pacific Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Feline Atopic Dermatitis Drug Market
10.3.6.1.1 Australia Feline Atopic Dermatitis Drug Market by Drug Class
10.3.6.1.2 Australia Feline Atopic Dermatitis Drug Market by Route Of Administration
10.3.6.1.3 Australia Feline Atopic Dermatitis Drug Market by Distribution Channel
10.3.6.2 China Feline Atopic Dermatitis Drug Market
10.3.6.2.1 China Feline Atopic Dermatitis Drug Market by Drug Class
10.3.6.2.2 China Feline Atopic Dermatitis Drug Market by Route Of Administration
10.3.6.2.3 China Feline Atopic Dermatitis Drug Market by Distribution Channel
10.3.6.3 India Feline Atopic Dermatitis Drug Market
10.3.6.3.1 India Feline Atopic Dermatitis Drug Market by Drug Class
10.3.6.3.2 India Feline Atopic Dermatitis Drug Market by Route Of Administration
10.3.6.3.3 India Feline Atopic Dermatitis Drug Market by Distribution Channel
10.3.6.4 Japan Feline Atopic Dermatitis Drug Market
10.3.6.4.1 Japan Feline Atopic Dermatitis Drug Market by Drug Class
10.3.6.4.2 Japan Feline Atopic Dermatitis Drug Market by Route Of Administration
10.3.6.4.3 Japan Feline Atopic Dermatitis Drug Market by Distribution Channel
10.3.6.5 South Korea Feline Atopic Dermatitis Drug Market
10.3.6.5.1 South Korea Feline Atopic Dermatitis Drug Market by Drug Class
10.3.6.5.2 South Korea Feline Atopic Dermatitis Drug Market by Route Of Administration
10.3.6.5.3 South Korea Feline Atopic Dermatitis Drug Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Feline Atopic Dermatitis Drug Market Overview
10.4.2 Middle East and Africa Feline Atopic Dermatitis Drug Market Forecasts and Analysis
10.4.3 Middle East and Africa Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Route Of Administration
10.4.5 Middle East and Africa Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Feline Atopic Dermatitis Drug Market
10.4.6.1.1 South Africa Feline Atopic Dermatitis Drug Market by Drug Class
10.4.6.1.2 South Africa Feline Atopic Dermatitis Drug Market by Route Of Administration
10.4.6.1.3 South Africa Feline Atopic Dermatitis Drug Market by Distribution Channel
10.4.6.2 Saudi Arabia Feline Atopic Dermatitis Drug Market
10.4.6.2.1 Saudi Arabia Feline Atopic Dermatitis Drug Market by Drug Class
10.4.6.2.2 Saudi Arabia Feline Atopic Dermatitis Drug Market by Route Of Administration
10.4.6.2.3 Saudi Arabia Feline Atopic Dermatitis Drug Market by Distribution Channel
10.4.6.3 U.A.E Feline Atopic Dermatitis Drug Market
10.4.6.3.1 U.A.E Feline Atopic Dermatitis Drug Market by Drug Class
10.4.6.3.2 U.A.E Feline Atopic Dermatitis Drug Market by Route Of Administration
10.4.6.3.3 U.A.E Feline Atopic Dermatitis Drug Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Feline Atopic Dermatitis Drug Market Overview
10.5.2 South and Central America Feline Atopic Dermatitis Drug Market Forecasts and Analysis
10.5.3 South and Central America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Route Of Administration
10.5.5 South and Central America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Feline Atopic Dermatitis Drug Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Feline Atopic Dermatitis Drug Market
10.5.6.1.1 Brazil Feline Atopic Dermatitis Drug Market by Drug Class
10.5.6.1.2 Brazil Feline Atopic Dermatitis Drug Market by Route Of Administration
10.5.6.1.3 Brazil Feline Atopic Dermatitis Drug Market by Distribution Channel
10.5.6.2 Argentina Feline Atopic Dermatitis Drug Market
10.5.6.2.1 Argentina Feline Atopic Dermatitis Drug Market by Drug Class
10.5.6.2.2 Argentina Feline Atopic Dermatitis Drug Market by Route Of Administration
10.5.6.2.3 Argentina Feline Atopic Dermatitis Drug Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. FELINE ATOPIC DERMATITIS DRUG MARKET, KEY COMPANY PROFILES
12.1. BAUSCH HEALTH COMPANIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAYER
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANOFI
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELI LILY
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BRISTOL-MYERS SQUIBB
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BOEHRINGER INGELHEIM
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ELANCO
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bausch Health Companies
2. Bayer
3. Pfizer
4. Novartis
5. Sanofi
6. Eli Lily
7. Bristol-Myers Squibb
8. Boehringer Ingelheim
9. Elanco

TIPRE00008619
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking